Galaxy Biomedical Investment Co (SZSE:000806) Days Sales Outstanding : 251.87 (As of Mar. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Galaxy Biomedical Investment Co Days Sales Outstanding?

Galaxy Biomedical Investment Co's average Accounts Receivable for the three months ended in Mar. 2023 was ¥680 Mil. Galaxy Biomedical Investment Co's Revenue for the three months ended in Mar. 2023 was ¥246 Mil. Hence, Galaxy Biomedical Investment Co's Days Sales Outstanding for the three months ended in Mar. 2023 was 251.87.

The historical rank and industry rank for Galaxy Biomedical Investment Co's Days Sales Outstanding or its related term are showing as below:

SZSE:000806's Days Sales Outstanding is not ranked ^*
in the Hardware industry.
Industry Median: 74.33
* Ranked among companies with meaningful Days Sales Outstanding only.

Galaxy Biomedical Investment Co's Days Sales Outstanding increased from Mar. 2022 (143.35) to Mar. 2023 (251.87).

Galaxy Biomedical Investment Co Days Sales Outstanding Historical Data

The historical data trend for Galaxy Biomedical Investment Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galaxy Biomedical Investment Co Days Sales Outstanding Chart

Galaxy Biomedical Investment Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Get a 7-Day Free Trial

282.18

222.82

140.44

148.33

139.06

Galaxy Biomedical Investment Co Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Days Sales Outstanding	Get a 7-Day Free Trial															143.35	114.95	170.92	159.64	251.87

Competitive Comparison of Galaxy Biomedical Investment Co's Days Sales Outstanding

For the Electronic Components subindustry, Galaxy Biomedical Investment Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galaxy Biomedical Investment Co's Days Sales Outstanding Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Galaxy Biomedical Investment Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Galaxy Biomedical Investment Co's Days Sales Outstanding falls into.

Galaxy Biomedical Investment Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Galaxy Biomedical Investment Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (492.161	+	672.142)	/	2 )	/	1527.995	*	365
=	582.1515					/	1527.995	*	365
=	139.06

Galaxy Biomedical Investment Co's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

	Days Sales Outstanding (Q: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (672.142	+	687.513)	/	2 )	/	246.294	*	365 / 4
=	679.8275					/	246.294	*	365 / 4
=	251.87

Galaxy Biomedical Investment Co (SZSE:000806) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Galaxy Biomedical Investment Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Galaxy Biomedical Investment Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Galaxy Biomedical Investment Co (SZSE:000806) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Galaxy Biomedical Investment Co Ltd (SZSE:000806) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Central Office Building, Yinhe Software Park, Beihai, Guangxi, CHN, 536000

Website

http://www.yinhetech.com

Galaxy Biomedical Investment Co Ltd is a China-based company engaged in the manufacture of electronic components.

Galaxy Biomedical Investment Co (SZSE:000806) Headlines

No Headlines